MassMutual Private Wealth & Trust’s Regenxbio RGNX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-38	Closed	-$294	–	2467
2024 Q4	$294	Sell	38 -174	-82%	-$1.63K	﹤0.01%	2221
2024 Q3	$2.22K	Buy	+212	New	+$2.58K	﹤0.01%	1628
2024 Q1	–	Sell	-76	Closed	-$1.36K	–	2118
2023 Q4	$1.36K	Buy	+76	New	+$1.34K	﹤0.01%	1621
2023 Q3	–	Sell	-329	Closed	-$6.58K	–	2034
2023 Q2	$6.58K	Buy	+329	New	+$6.34K	﹤0.01%	1115
2023 Q1	–	Sell	-52	Closed	-$1K	–	1876
2022 Q4	$1K	Buy	+52	New	+$1.18K	﹤0.01%	1526
2022 Q2	–	Sell	-174	Closed	-$6K	–	1680
2022 Q1	$6K	Hold	174	–	–	﹤0.01%	884
2021 Q4	$6K	Hold	174	–	–	﹤0.01%	867
2021 Q3	$7K	Hold	174	–	–	﹤0.01%	802
2021 Q2	$7K	Hold	174	–	–	﹤0.01%	766
2021 Q1	$6K	Hold	174	–	–	﹤0.01%	694
2020 Q4	$8K	Buy	174 +94	+118%	+$3.29K	﹤0.01%	637
2020 Q3	$2K	Buy	+80	New	+$2.61K	﹤0.01%	690

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

MassMutual Private Wealth & Trust's RGNX Position: Q1 2025 in Review

MassMutual Private Wealth & Trust sold out of Regenxbio (RGNX) in Q1 2025, closing a stake of 38 shares — an estimated $294 sold.

MassMutual Private Wealth & Trust first reported a position in RGNX in Q3 2020 and held it in 12 quarters. The position peaked at $8K in Q4 2020. 164 funds tracked by Wall St. Rank hold RGNX as of Q1 2025.

MassMutual Private Wealth & Trust reported no remaining Regenxbio position as of Q1 2025 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 38 Regenxbio shares in Q1 2025, an estimated $294.
MassMutual Private Wealth & Trust first reported a position in Regenxbio in Q3 2020 and held it in 12 quarters.
MassMutual Private Wealth & Trust's Regenxbio position peaked at $8K in Q4 2020.
164 funds tracked by Wall St. Rank held Regenxbio as of Q1 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2025, filed 1 Apr 2025.